Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,139.83
+60.97
(+0.75%)
FTSE 250
19,824.16
+222.18
(+1.13%)
AIM
755.28
+2.16
(+0.29%)
GBP/EUR
1.1679
+0.0022
(+0.19%)
GBP/USD
1.2502
-0.0009
(-0.07%)
Bitcoin GBP
51,199.54
-436.43
(-0.85%)
PROPERTY
9 luxury homes to consider if money is no object
Ever thought about what a multimillion pound budget would buy you?
Cyclo Therapeutics, Inc. (CYTH)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2900
-0.0400
(-3.01%)
As of 02:26PM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,076
1,076
1,376
1,586
903.376
Cost of revenue
84.367
84.367
138.929
156.08
66.398
Gross profit
992.038
992.038
1,237
1,430
836.978
Operating expenses
Research development
14,182
14,182
9,000
9,154
6,096
Selling general and administrative
5,666
5,666
6,793
5,455
3,173
Total operating expenses
21,042
21,042
16,848
15,698
9,797
Operating income or loss
-20,050
-20,050
-15,612
-14,268
-8,960
Total other income/expenses net
-7.245
-7.245
160.726
-18.522
18.53
Income before tax
-20,057
-20,057
-15,451
-14,287
-8,942
Income tax expense
0
0
0
0
0
Income from continuing operations
-20,057
-20,057
-15,451
-14,287
-8,942
Net income
-20,057
-20,057
-15,451
-14,287
-8,942
Net income available to common shareholders
-20,057
-20,057
-15,451
-14,287
-8,942
Basic EPS
-1.59
-
-1.83
-2.24
-5.60
Diluted EPS
-1.59
-
-1.83
-2.24
-5.60
Basic average shares
12,914
-
8,439
6,370
1,599
Diluted average shares
12,914
-
8,439
6,370
1,599
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.